In B-cell lymphomas, such as chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL), as well as in T cell tumors, BTLA is frequently expressed on tumor-derived lymphocytes and is associated with a poor prognosis. This evidence concerns the gene BTLA and neoplasm.